Leo Cancer Care are Now Providing Particle Therapy Quality Assurance Products in Partnership with Detector

We are delighted to announce that Leo Cancer Care is now supplying Detector’s state-of-the-art, Particle Therapy Quality Assurance products to the US.

Leo Cancer Care is now offering a full range of Detector Quality Assurance products to monitor charged particle therapeutic beams during daily quality control.

Leo Cancer Care will be bringing six of Detector’s Quality Assurance products to the US Particle Therapy Market, all the listed products are FDA approved and CE marked:

• QEye - Is the innovative QA system for range and modulation verification in eye tumour therapy

• QUBEnext - The ultimate all-in-one QA device to get full-beam characterisation in a single shot

• Q360 - Is the particle detector for beam intensity and profile measurements, specifically designed for the full characterisation of large clinical radiation fields

• NextQ - A unique beam profile measurement device, it is an all-in-one device, designed to be both light and robust with its aluminium case

• QPlus - Is the ideal, all-in-one QA devices to get profile measurements of beam spots in ocular proton treatments

• AQuracy - Is a beam profiling system for spot characterisation and machine QA

Full details of these products are now listed on the Leo Cancer Care website.

Leo Cancer Care will bring their expertise in the Particle Therapy space together with Detector’s wealth of QA measurement knowledge to provide a fully integrated QA solution to the US market.

If you are interested in finding out more about these products and to enquire about prices, please contact Harry Freeman at harry@leocancercare.com.

Detector’s Particle Therapy Quality Assurance Products